“Comprehensive in-Silico Characterization of Deleterious IDH2 Variants and Their Structural and Functional Implications in Acute Myeloid Leukemia: In-Silico for Deleterious IDH2 Variants and Functional Implications in AML” (2026) Futuristic Biotechnology, 6(2), pp. 25–32. doi:10.54393/fbt.v6i2.238.